Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: A case-control study in the UK

British Journal of Cancer

Volumn 92, Issue 9, 2005, Pages 1794-1799

  Grainge, M J ^a   Seth, R ^a   Coupland, C ^a   Guo, L ^a   Rittman, T ^a   Vryenhoef, P ^b   Johnson, J ^b   Jenkins, D ^a   Neal, K R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Case control study; Cervical neoplasia; Human papillomavirus; Older women; United Kingdom

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GREAT BRITAIN; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 19944376829     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602538     Document Type: Article

References (23)

1. Carozzi F, Ronco G, Confortini M, Noferini D, Maddau C, Ciatto S, Segnan N (2000) Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer 83: 1462-1467, doi:10.1054/bjoc.2000.1491
2. Chua KL, Hjerpe A (1995) Polymerase chain reaction analysis of human papillomavirus in archival cervical cytologic smears. Anal Quant Cytol Histol 17: 221-229
3. Cruickshank ME, Chambers G, Murray G, McKenzie L, Donaldson C, Andrews J, Campbell MK, Kitchener HC (2002) Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease. Int J Gynaecol Cancer 12: 735-740
4. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057-1062
5. Flannelly G, Monaghan J, Cruickshank M, Duncan I, Johnson J, Jordan J, Campbell M, Patnick J (2004) Cervical screening in women over the age of 50: results of a population-based multicentre study. BJOG 111: 362-368, doi:10.1111/j.1471-0528.2004.00085.x
6. Jacobs MV, Zielinski D, Meijer CJLM, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJF, Walboomers JMM (2000) A simplified and reliable HPV testing of archival papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 82: 1421-1426, doi: 10.1054/bjoc.1999.1128
7. Kjaer SK, van den Brule AJC, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJLM (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325: 572-576
8. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB (1992) A cohort study of the risk of cervical intrapithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272-1278
9. Liaw K-L, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, Burk RD, Kurman RJ, Wacholder S, Rush BB, Cadell DM, Lawler P, Tabor D, Schiffman M (1999) Detection of human papillomavirus DNA in cytologically normal women and subsequent squamous intraepithelial lesions. J Natl Cancer Inst 91: 954-960
10. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM (2003) Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527
11. Qiagen UK (2004a) DNEasy tissue kit handbook, http://wwwl.qiagen.com/ products/genomicdnastabilizationpurification/dneasytissuesystem/dneasytissuekit. aspx?ShowInfo = 1.Accessed 26/10/2004
12. Qiagen UK (2004b) QuantiTect™ SYBR® Green PCR Handbook. http://www 1.qiagen.com/literature/handbooks/PDF/PCRAndReverseTranscription/ KitsAndEnzymes/PCR_QT_SYBR_Green/1024444HB_PCRQTect_0803. pdf.Accessed 26/10/2004
13. Royal College of Pathologists (1999) Consensus Statement of Recommended Policies for Uses of Human Tissue in Research Education and Quality Control, London
14. Schlecht NF, Platt RW, Negassa A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco E (2003) Modelling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. Am J Epidemiol 158: 878-886, doi:10.1093/aje/kwg235
15. Seth R, Nolan T, Davey T, Rippin J, Guo L, Jenkins D (2004) Simultaneous detection and sub-typing of human papillomavirus in the cervix using real-time quantitative PCR. In A-Z of quantitative PCR, Bustin SA (ed) pp 783-795. California: International University Line
16. Sherlaw-Johnson C, Gallivan S, Jenkins D (1999) Withdrawing low risk women from cervical screening programmes: mathematical modelling study. BMJ 318: 356-360
17. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doom LJ, van den Tweel J (2002) Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156: 158-164, doi:10.1093/aje/kwf013
18. Walboomers JMM, de Roda Husman AM, Snijders PJ, Stel HV, Risse EK, Heimerhorst TJ, Voorhorst FJ, Meijer CJLM (1995) Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728-732
19. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19
20. Wallin K-L, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633-1638
21. Woodman CBJ, Collins S (2002) A critique of cohort studies examining the role of human papillomavirus infection in cervical neoplasia. BJOG 109: 1311-1318
22. Ylitalo N, Josefsson A, Melbye M, Sorensen P, Frisch M, Andersen PK, Sparen P, Gustafsson M, Magnusson P, Ponten J, Gyllensten U, Adami H-O (2000) A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60: 6027-6032
23. Zielinski GD, Snijders PJ, Rozendaal L, Voorhorst FJ, van der Linden HC, Runsink AP, de Schipper FA, Meijer CJ (2001) HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 85: 398-404, doi:10.1054/bjoc2001.1926